Deloitte LLP   Deloitte LLP
 
Convergence in Life Sciences
Beyond traditional boundaries

Life sciences firms are moving beyond traditional industry boundaries to create new health care solutions for patients and providers. Recent scientific advances and improvements in enabling technologies have opened new avenues for convergence among drugs, diagnostics and devices. Aging populations and rising consumerism are increasing demand for health care products that offer greater effectiveness and convenience. These shifting industry and market conditions are creating both pressures and new opportunities for life sciences companies. Explore the links below to learn more about the move toward convergence. 

converging buildings

Podcast: Searching For Convergence Solutions - How Combination Products Are Transforming Health Care
The trend toward convergence has been accelerating lately thanks to scientific advances, consumer demand and the need to rein in health care costs. In this Deloitte Insights podcast, industry leaders discuss how life sciences companies can seize the opportunities convergence presents by embracing new kinds of alliances.

test tubes

Point of View: Managing Pathways to Convergence in the Life Sciences Industry
We provide various examples of convergence, identify the driving forces behind the trend and discuss pathways to convergence in the marketplace today. 

telescope

Research: The Future of the Life Sciences Industries - Strategies for Success in 2015 
Our survey indicated that life sciences companies are likely facing a great deal of upheaval, and they will need to reinvent their strategies to succeed.

webcast

Webcast: Demystifying and Realizing the Potential of Drug, Device and Diagnostic Convergence
How is the convergence of drugs, devices and diagnostics impacting innovation, business growth and product differentiation in life sciences? Industry leaders discuss in this Webcast.

hand shake

Article: Convergence in the Life Sciences Industry - Can Partnering Make a Significant Impact? 
In 2008 and beyond, combination products are expected to provide life sciences companies with new avenues for growth and differentiation.
 

Related Content: 
Interview: Life Sciences Industry - Converging for Better Care
Overview: Catch the Life Sciences Wave 
Overview: Life Sciences & Health Care in Emerging Markets
Services: Life Sciences 

Stay Connected: Subscriptions
Sign up to receive the latest insights and ideas from the Deloitte Life Sciences industry practice and the Deloitte Center for Health Solutions. Receive e-alerts when new research, Dbriefs Webcasts and podcasts are available (free; registration required). Subscribe to receive e-mail notifications. 

As used in this document, ‘Deloitte’ means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

Contact us for more information
 
Last Updated: July 1, 2008
Source: Deloitte LLP - United States (English)

Print this page    Email to a colleague
     

Copyright © 2008 Deloitte Development LLC. All rights reserved. About Deloitte US.

Deloitte RSS FeedsDeloitte RSS Feeds | What’s RSS?Bookmark